[Simplified ambulatory treatment of thrombosis. A daily dosage of subcutaneous low-molecular-weight heparin].
Of 162 patients aged 27-28 years, referred during a 12-month period to the Dept. of medicine, Norrköping Central Hospital, for deep vein thrombosis (DVT), 102 (63 per cent) were treated as out-patients with the low molecular weight heparin preparation, dalteparin (Fragmin), given subcutaneously at a standardised daily dosage of 200 U/kg. No serious thrombotic events were reported. The frequency of post-thrombotic symptoms at six months did not differ from that among hospitalised patients on standard heparin treatment. Thus, the proportion of DVT patients treated as in-patients was reduced by 50 per cent, despite a 33 per cent increase in the number of referrals for DVT during the period. At follow-up, almost 90 per cent of the patients expressed satisfaction with the out-patient routines.
Hallert
C
C
Medicinkliniken, Lasarettet i Norrköping.
Blomqvist
K
K
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D013548:Sweden; D015912:Thrombolytic Therapy / Q000191:economics / Q000379:methods*; D013924:Thrombophlebitis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight
Förenklad trombosbehehandling iöppen vård. Lågmolekylärt heparin subkutant i en daglig dos.